Kestrel Therapeutics Inc. (“Kestrel” or the “Company”), a clinical stage biotechnology company developing next-generation ...

In the Phase 2/3 COMPANION-002 study of tovecimig (DLL4 x VEGF-A bispecific antibody) in patients with biliary tract cancer, the prespecified ...

SHANNON, CLARE, IRELAND, February 27, 2026 /EINPresswire.com/ -- Announcing a new publication from Opto-Electronic ...

Announcing a new publication from Opto-Electronic Advances; DOI 10.29026/oea.2026.250177 .Light, as a core carrier of information, possesses multiple ...

A suspended chalcogenide waveguide achieves record ppb-level gas detection in the near-infrared, enhancing sensitivity for ...

Nuclear magnetic resonance –based co-magnetometers are essential tools for applications ranging from inertial navigation to geophysical exploration and biomedical sensing. Their performance critically ...

Sanofi’s multiple sclerosis hopeful tolebrutinib faced dual setbacks on Monday, with a late-stage failure in one form of the disease and yet another regulatory setback in another. Sanofi reported a ...

DT-101 is designed to allow effective modulation of the AMPA receptor without compromising safety Phase 2 clinical trial initiation anticipated before the end of 2025 Trial builds on positive Phase 1 ...

ABSTRACT: This paper presents a comparative study of four Sinusoidal Pulse Width Modulation (SPWM) strategies Phase Disposition (PD-PWM), Phase Opposition Disposition (POD-PWM), Alternate Phase ...